161 related articles for article (PubMed ID: 17251527)
1. Debating the risks of drug-eluting stents.
Shuchman M
N Engl J Med; 2007 Jan; 356(4):325-8. PubMed ID: 17251527
[No Abstract] [Full Text] [Related]
2. Concerns over safety of drug-eluting stents.
Expert Rev Med Devices; 2006 Nov; 3(6):689-90. PubMed ID: 17280532
[No Abstract] [Full Text] [Related]
3. Stent thrombosis redux--the FDA perspective.
Farb A; Boam AB
N Engl J Med; 2007 Mar; 356(10):984-7. PubMed ID: 17296827
[No Abstract] [Full Text] [Related]
4. Off-label use of drug-eluting stents putting it in perspective.
Grines CL
J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
[No Abstract] [Full Text] [Related]
5. Unanswered questions--drug-eluting stents and the risk of late thrombosis.
Maisel WH
N Engl J Med; 2007 Mar; 356(10):981-4. PubMed ID: 17296826
[No Abstract] [Full Text] [Related]
6. Trading restenosis for thrombosis? New questions about drug-eluting stents.
Shuchman M
N Engl J Med; 2006 Nov; 355(19):1949-52. PubMed ID: 17093244
[No Abstract] [Full Text] [Related]
7. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
Waksman R; Weinberger J
Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
[No Abstract] [Full Text] [Related]
8. The rush is on to acquire drug-eluting stents.
Hosp Mater Manage; 2003 Jun; 28(6):2, 11. PubMed ID: 12825380
[No Abstract] [Full Text] [Related]
9. Problems with drug-eluting coronary stents--the FDA perspective.
Muni NI; Gross TP
N Engl J Med; 2004 Oct; 351(16):1593-5. PubMed ID: 15483274
[No Abstract] [Full Text] [Related]
10. [Drug-eluting stents can increase the risk of late stent thrombosis].
Skyttberg N; Linder R; Carlsson J
Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
[No Abstract] [Full Text] [Related]
11. Late thrombosis and drug-eluting stents.
Williams D
Med Device Technol; 2006; 17(9):8, 10. PubMed ID: 17240679
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting coronary stents--promise and uncertainty.
Curfman GD; Morrissey S; Jarcho JA; Drazen JM
N Engl J Med; 2007 Mar; 356(10):1059-60. PubMed ID: 17296828
[No Abstract] [Full Text] [Related]
13. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
14. Coronary stents: current status.
Garg S; Serruys PW
J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S1-42. PubMed ID: 20797502
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stents is their future as bright as their past?
Kastrati A; Schömig A
J Am Coll Cardiol; 2007 Jul; 50(2):146-8. PubMed ID: 17616298
[No Abstract] [Full Text] [Related]
16. TCT Daily: safety profile of drug-eluting stents similar to bare-metal stents: lower restenosis rates associated with DES.
Kahn J
J Interv Cardiol; 2007 Feb; 20(1):30-1. PubMed ID: 17300395
[No Abstract] [Full Text] [Related]
17. Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
Kandzari DE; Farb A; Boam AB
Circ Cardiovasc Interv; 2009 Dec; 2(6):574-9. PubMed ID: 20031776
[No Abstract] [Full Text] [Related]
18. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis.
J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397
[No Abstract] [Full Text] [Related]
19. Stent thrombosis in the era of drug eluting stents.
Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
Rossini R; Musumeci G; Aprile A; Valsecchi O
Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
